Skip to main content
Premium Trial:

Request an Annual Quote

AmoyDx Cancer Detection Kit Approved by Chinese Regulators

NEW YORK (GenomeWeb News) –Amoy Diagnostics today said that China's State Food and Drug Administration has approved the company's EML4-ALK Fusion Gene Detection Kit for marketing in that country.

The approval allows Amoy to market the kit, which received CE Marking in January, for clinical use.

The assay detects 21 fusion products from rearrangements of the EML4 and ALK genes and uses a two-step process to detect mutations in tumor nucleic acids. It and Amoy's other SFDA-approved and CE-marked assays, including its EGFR, KRAS, BRAF, and PIK3CA mutation detection kits, have been validated on PCR instruments from several manufacturers, the Xiamen, China-based company said.

"Our goal is to provide a comprehensive panel of molecular tests that will quickly and reliably identify driver mutations in cancer tissue so that patients can receive the most appropriate treatment based on the mutation profile of their tumor," David Whyte, VP of global development, said in a statement. "We believe firmly that real-time PCR is the technology of choice for therapeutic target identification, due to its ease of use and high sensitivity."

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.